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disease management ( r =  –0.243,  p = 0.001), and healthy liv-
ing choices ( r =  –0.237,  p = 0.002). The perception that some 
physicians and patients have of pharmacists as dispensers 
only was identified as the most important barrier to provid-
ing diabetes-related services.  Conclusion: Pharmacists 
have positive diabetes-related attitudes; however, they 
provide limited diabetes-related services to their patients. 
Barriers to provision of pharmacy services to patients with 
diabetes should be addressed to enable optimum patient 
care delivery.  © 2017 S. Karger AG, Basel 
 Introduction 
 International standards for diabetes care have recog-
nized the crucial role of pharmacists in diabetes manage-
ment  [1, 2] . Pharmacists may provide many services be-
yond dispensing medications, including management of 
medication therapy, reconciliation of medication, pre-
ventive care services such as screening and immuniza-
tion, as well as education and behavioral counseling  [1, 
2] . Collaboration among physicians, nurses, dieticians, 
and pharmacists is required to ensure optimum patient 
care and adequate diabetes management  [3–6] . Health 
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 Abstract 
 Objectives: The objectives of this study were to measure 
pharmacists’ attitudes toward management of diabetes, 
identify current levels of pharmacy service provided to pa-
tients with diabetes, and identify barriers for further provi-
sion of diabetes-related services.  Subjects and Methods: A 
descriptive, cross-sectional study was conducted on a sam-
ple of 198 pharmacists working in primary and secondary 
health care settings in one health region of Kuwait using a 
pretested self-administered questionnaire. Descriptive sta-
tistics, correlations, and comparative analysis were per-
formed.  Results: The response rate was 84.4% ( n = 168). Re-
spondents had overall positive attitudes toward manage-
ment of diabetes. Pharmacists regularly provided their 
patients with counseling on the appropriate time to admin-
ister their medications; however, services related to hypo-
glycemia and management of comorbid diseases were rare-
ly provided. A negative correlation was found between the 
positive overall diabetes-related attitudes and pharmacists’ 
involvement in providing the following diabetes-related 
services: glucose monitoring ( r =  –0.25,  p = 0.001), comorbid 
 Received: April 5, 2016 
 Accepted: January 15, 2017 
 Published online: January 18, 2017 
 Asmaa A. Al-Haqan, BPharm, MSc Clinical Pharmacy  
 Department of Pharmacy Practice  
 Faculty of Pharmacy, Kuwait University  
 PO Box 24923 Safat 13110 (Kuwait) 
 E-Mail asmaa_h   @   hsc.edu.kw  
 © 2017 S. Karger AG, Basel 
 www.karger.com/mpp 
Th is is an Open Access article licensed under the terms of the
Creative Commons Attribution-NonCommercial 3.0 Un-
ported license (CC BY-NC) (www.karger.com/OA-license), 
applicable to the online version of the article only. Distribu-
tion permitted for non-commercial purposes only.
 Al Haqan/Al-Taweel/Awad/Wake
 
Med Princ Pract 2017;26:273–279
DOI: 10.1159/000456088
274
care settings that adopt a multidisciplinary team ap-
proach in the management of diabetes improve efficiency 
and cost-effectiveness of diabetes care  [3, 4] . The inter-
ventions of pharmacists have been proven to improve 
glycemic control  [3, 5, 6] , empower patients to self-man-
agement  [7] , and increase patients’ satisfaction and qual-
ity of life  [8–10] . 
 A report from the National Diabetes Commission sug-
gested that an inappropriate attitude of health care pro-
fessionals toward diabetes could lead to poor patient out-
comes  [11] . This led to the development of the Diabetes 
Attitudes Scale (DAS) in 1989  [12] . The DAS was de-
signed to measure diabetes-related attitudes/beliefs, and 
following several modifications is now in its third version 
 [13] . Previous studies had indicated that pharmacists’ at-
titudes toward diabetes are generally positive  [14–16] ; 
however, this might not correlate with the degree of their 
involvement in diabetes patient education  [14, 15] . The 
frequency of providing diabetes-related services varied 
throughout the different studies  [15, 16] . This could be 
linked to the diverse practice settings, evolving role of the 
pharmacists, differences in teaching curricula of pharma-
cy schools, pharmacists becoming more involved in di-
rect patient care, and cultural diversity. Moreover, the 
current literature provides limited information on types 
of services provided by pharmacists in different practice 
settings (community, primary care, and hospital) and 
whether the setting has an impact on attitudes  [15, 16] . 
 Although globally the pharmacist’s role has changed 
from dispensing to drug therapy management, the phar-
macist’s role in Kuwait is still largely limited to dispensing 
and pharmacy administration (e.g., stock management, 
medication orders, and record keeping)  [17] . There is a 
lack of clear local guidelines clarifying patient-related 
pharmacists’ activities. The present study was therefore 
designed to measure pharmacists’ attitude toward diabe-
tes management, to identify pharmacy services that are 
currently provided to patients with diabetes in Kuwait, 
and determine whether or not these activities differ be-
tween primary and secondary health care settings, and to 
identify barriers to provision of additional diabetes-relat-
ed services. 
 Subjects and Methods 
 Study Design and Population  
 A descriptive, cross-sectional survey-based study was conduct-
ed in Kuwait, a Middle-Eastern country with an estimated popula-
tion of 3,065,850 people; 35.6% of whom are Kuwaitis (2011 esti-
mate)  [18] . The survey was conducted during the period of Febru-
ary to April 2015. Kuwait is divided into 6 health care regions in 
which there are a total of 6 public general hospitals and 79 public 
primary care clinics in addition to several private hospitals and 
clinics. Diabetes clinics are run in primary care clinics and in all 
general hospitals in Kuwait. 
 Convenience sampling was used to choose 1 health region: Ha-
walli Health Region. All pharmacists working in primary and sec-
ondary health care settings in Hawalli Health Region were includ-
ed in the study ( n = 198). In this study, the term “primary care” is 
defined as the first point of contact for patients with health care, 
where the services are provided by a primary care physician (gen-
eral practitioner or family physician). In Kuwait this is usually a 
polyclinic. The term “secondary care” is defined as health care ser-
vices provided by specialists in a hospital setting (outpatient
or inpatient), which includes acute care in hospital emergency
departments. The Ethics Review Committee of Dasman Diabetes 
Institute, Kuwait, approved the study, and also permission was
obtained from the necessary governing bodies of the respective 
primary care polyclinics, private hospitals, and public hospitals
in the Ministry of Health, Kuwait.
 Questionnaire Design  
 The questionnaire contained 4 different sections: (a) partici-
pants’ demographics, (b) measured participants’ attitude toward 
diabetes using the Diabetes Attitude Scale-Version 3 (DAS-3)  [13] , 
(c) a list of possible diabetes patient support activities that could 
be delivered by pharmacists, and (d) a list of barriers to providing 
more diabetic services to patients. 
 The DAS-3 was used to measure participants’ degree of agree-
ment to 33 diabetes-related statements, on a 5-point Likert type 
scale (strongly disagree: 1; disagree: 2; neutral: 3; agree: 4, and 
strongly agree: 5). The list of possible diabetes-related services was 
constructed based on a literature review  [3, 4, 15, 16, 19] of the role 
of pharmacists in diabetes management. In this section, the fre-
quency of providing relevant information/activities to patients was 
measured as: never = 0%, rarely = 25%, often = 75%, or always = 
100%. The barriers investigated included the perception that some 
physicians or patients have of pharmacists as dispensers only, lack 
of collaboration with other health care providers, lack of organiza-
tion, administrative factors, inadequate documentation, and lack 
of facilities (e.g., counseling room). Content and face validity of the 
questionnaire were established by means of a pilot study on 11 
pharmacists, and changes were made as necessary prior to roll-out. 
The questionnaire used in this study is available online (see suppl. 
online material; see www.karger.com/doi/10.1159/000456088 for 
all online suppl. material). 
 Data Collection 
 One hundred and ninety-eight pharmacists were approached; 
the questionnaires were given to those who agreed to participate 
and they were completed anonymously. Questionnaires were 
distributed in person by the researcher. All sites were visited 
once to distribute the questionnaires and subsequently to collect 
them. Subsequent visits were done as a reminder to those par-
ticipants who did not complete the questionnaire at the first vis-
it. All participants signed an informed consent form and were 
informed about the confidentiality of the collected data before 
participation. Incentives were not offered for completion of the 
questionnaire. The time required for completion of the ques-
tionnaire was around 15–20 min. Negatively worded items were 
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rescored with the appropriate scale conversion so that the high-
er scores on all items reflected more positive attitudes towards a 
factor  [11] .
 Data Analysis  
 Data analysis was accomplished using IBM SPSS Statistics for 
Windows, version 22 (IBM Corp., Armonk, N.Y., USA). Demo-
graphic characteristics were summarized using frequencies and 
percentages. Respondents’ attitudes toward diabetes were present-
ed as medians and interquartile range (IQR). Statistical correla-
tional analysis (Spearman’s rank correlation) was used to measure 
the association between diabetes attitudes and provision of diabe-
tes services to patients. Mann-Whitney and Kruskal-Wallis tests 
were used to evaluate the differences in medians between the 
groups of predictor variables, and diabetes attitudes subscales and 
diabetes services. Statistical significance for all analysis was defined 
as  p < 0.05. The predictor variables were categorized as follows: (a) 
age: 20–29; 30–39; 40–49, and  ≥ 50 years; (b) gender: male and fe-
male; (c) years of practice: 0–5; 6–10, and >10 years; (d) practice 
sites: primary care or secondary care; (e) level of education: first 
degree (BPharm, Mpharm, and PharmD) and postgraduate degree 
(MSc and PhD); (f) university: Kuwait University and non-Kuwait 
University graduates; (g) interest in diabetes: yes, no; and (h) spe-
cial diabetes continuing education in the past: yes, no.
 With regards to the diabetes-related services, the internal con-
sistency for each group of diabetes services that pharmacists may 
provide to patients with diabetes was assessed using Cronbach α 
test. The test results were as follows: 5 statements of blood glucose 
monitoring (0.88), 3 statements of hypoglycemia management 
(0.85), 10 statements of general pharmacotherapy management in-
cluding insulin and oral antidiabetic drugs (0.87), 9 statements of 
comorbid disease management (0.92), and 4 statements of healthy 
living choices (0.82).
 Results  
 Of the 198 pharmacists approached, 168 (84.8%) 
agreed to participate and completed the questionnaire. 
Respondents’ demographic characteristics are shown in 
 Table 1 . Of the 168 respondents, 71 (42.3%) were in the 
age group of 30–39 years. The majority of respondents
( n = 94; 56%) were female, 135 (80.4 %) of the respon-
dents indicated an interest in diabetes, but 126 (75%) did 
not complete special diabetes continuing education. 
 The overall DAS-3 and subsets scores are given in
 Table 2 . In general, all the respondents expressed positive 
attitudes in all DAS-3 subscales. Higher positive attitudes 
were found among all the participants scoring high in the 
“need for special training in education” subscale (median 
4.4, IQR [4.0 – 4.8]) compared to other subscales. In com-
parison with secondary care pharmacists, it was found 
that pharmacists working in primary care ( n = 44, 26.2%) 
held significantly more positive attitudes with regards to 
the psychosocial impact of the diabetes subscale ( p = 
0.01). There were no significant differences between those 
working in primary and secondary care regarding the 
overall DAS-3 and other subscales ( p > 0.05).




20 – 29 61 (36.3)







6 – 10 32 (19.0)
>10 77 (45.9)
Practice Site
Primary care 44 (26.2)









Other 113 (67.3) 
Is diabetes an area that interests you?
Yes 135 (80.4)
No 33 (19.6)




 Table 2.  Diabetes Attitude Scale-Version 3 (DAS-3) and subscale 
scores (n = 168)
Items, n Median (IQR)
Total DAS-3 33 3.8 (3.6 – 4.0)
Five subsets of DAS-3
Need for special training 5 4.4 (4.0 – 4.8)
Seriousness of type 2 diabetes 7 3.8 (3.3 – 4.1)
Value of tight control 7 3.6 (3.2 – 3.9)
Psychosocial impact of DM 6 3.8 (3.5 – 4.27)
Patient autonomy 8 3.6 (3.4 – 3.9)
 IQR, Interquartile range.
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 Younger pharmacists aged 20–29 years ( n = 61; 36.3%) 
and 30–39 years ( n = 71; 42.3%) had significantly more 
positive attitudes toward the need for special training 
compared to the group aged  ≥ 40 years ( n = 36; 21.4%)
( p = 0.03 and 0.02, respectively). Female pharmacists
( n = 94; 56.0%) held more positive attitudes regarding the 
value of tight control of blood glucose than male pharma-
cists ( n = 74; 44.0%) ( p = 0.01). In addition, pharmacists 
who graduated from Kuwait University ( n = 55; 32.7%) 
had the following more significantly compared to gradu-
ates from other universities ( n = 113; 67.3%): positive 
overall attitudes towards diabetes ( p = 0.01), the need for 
special training ( p = 0.03), the severity of type 2 diabetes 
( p = 0.001), and the value of tight control of blood glucose 
( p = 0.005). There were no significant differences between 
the other respondents’ characteristics and their diabetes-
related attitudes ( p > 0.05). 
 Table 3.  Frequency of providing diabetes-related services to patients with diabetes (n = 168)




Never Rarely Often Always 
Services related to blood glucose monitoring
Counsel on the use of a blood glucose meter, including how to obtain a blood sample 64 (38.1) 41 (24.4) 37 (22.0) 26 (15.5) 2 (1 – 3)
Counsel on the appropriate times to check blood glucose 43 (25.6) 57 (33.9) 51 (30.4) 17 (10.1) 2 (1 – 3)
Counsel on the current treatment targets for blood glucose 34 (20.2) 51(30.4) 61 (36.3) 22 (13.1) 2 (2 – 3)
Counsel on the interpretation of A1C results 52 (31.0) 59 (35.1) 47 (28.0) 10 (6.0) 2 (1 – 3)
Provide drug therapy recommendations to the physician to help the patient reach blood 
glucose targets
47 (28.0) 56 (33.3) 38 (22.6) 27 (16.1) 2 (1 – 3)
Overall median 2 (1 – 3)
Services related to hypoglycemia management
Counsel on signs and symptoms of hypoglycemia 22 (13.1) 59 (35.1) 56 (33.3) 31 (18.5) 3 (2 – 3)
Identify possible causes of hypoglycemia 20 (11.9) 65 (38.7) 58 (34.5) 25 (14.9) 2 (2 – 3)
Provide recommendations for treatment of hypoglycemia to the patient 21 (12.5) 46 (27.4) 68 (40.5) 33 (19.6) 3 (2 – 3)
Overall median 3 (2 – 3)
Services related to pharmacotherapy
Conduct a drug history, including
Prescription medications 18 (10.7) 45 (26.8) 49 (29.2) 56 (33.3) 3 (2 – 4)
Over-the-counter products 32 (19.0) 48 (28.6) 62 (36.9) 26 (15.5) 3 (2 – 3)
Herbal and natural products 38 (22.6) 55 (32.7) 51 (30.4) 24 (14.3) 2 (2 – 3)
Review the patient’s drug refill history to identify poor adherence 26 (15.5) 51 (30.4) 54 (32.1) 37 (22.0) 3 (2 – 3)
Counsel on the appropriate use of syringes and needles (e.g., sharp disposal) 18 (10.7) 36 (21.4) 71 (42.3) 43 (25.6) 3 (2 – 4)
Counsel on the appropriate use of insulin pens 9 (5.4) 28 (16.7) 74 (44.0) 57 (33.9) 3 (3 – 4)
Counsel on the appropriate storage of insulin 7 (4.2) 21 (12.5) 61 (36.3) 79 (47.0) 3 (3 – 4)
Counsel on appropriate insulin administration (mixing insulin, injection technique, 
timing of injection, rotation of sites)
11 (6.5) 40 (23.8) 56 (33.3) 61 (36.3) 3 (2 – 4)
Describe the appropriate time to administer each oral antidiabetic drug 5 (3.0) 12 (7.1) 52 (31.0) 99 (58.9) 4 (3 – 4)
Describe potential adverse effects of each oral antidiabetic drug 10 (6.0) 51 (30.4) 70 (41.7) 37 (22.0) 3 (2 – 3)
Overall median 3 (2 – 3)
Services related to comorbid disease management
Recommend antiplatelet therapy to the patient’s physician 70 (41.7) 50 (29.8) 31 (18.5) 17 (10.1) 2 (1 – 3)
Provide education on the importance of controlling blood pressure in diabetes 26 (15.5) 59 (35.1) 58 (34.5) 25 (19.9) 2 (2 – 3)
Provide drug therapy recommendations to the physician to help the patient reach blood
pressure targets
55 (32.7) 48 (28.6) 46 (27.4) 19 (11.3) 2 (1 – 3)
Provide education on the importance of regular screening of nephropathy
(e.g., type of test, where to get the test, how often to test)
50 (29.8) 56 (33.3) 39 (23.2) 23 (13.7) 2 (1 – 3)
Review the patient’s drug profile to identify drugs that are renally cleared 56 (33.3) 52 (31.0) 35 (20.8) 25 (14.9) 2 (1 – 3)
Provide education on the importance of regular screening for neuropathic pain 50 (29.8) 59 (35.1) 39 (23.2) 20 (11.9) 2 (1 – 3)
Provide education on the importance of regular screening for retinopathy 50 (29.8) 56 (33.3) 46 (27.4) 16 (9.5) 2 (1 – 3)
Counsel on good foot care techniques 46 (27.4) 49 (29.2) 47 (28.0) 26 (15.5) 2 (1 – 3)
Provide education on the importance of diabetes foot care 47 (28.0) 53 (31.5) 38 (22.6) 31 (17.9) 2 (1 – 3)
Overall median 2 (1 – 3)
Services related to healthy living choices
Provide education about the importance of immunization for influenza and
pneumococcal pneumonia in diabetes
72 (42.9) 52 (31.0) 33 (19.6) 11 (6.5) 2 (1 – 3)
Provide basic information on diet as it relates to diabetes management 26 (15.5) 51 (30.4) 66 (39.3) 25 (14.9) 3 (2 – 3)
Provide basic information on exercise as it relates to diabetes management 23 (13.7) 49 (29.2) 69(41.1) 27 (16.1) 3 (2 – 3)
Overall median 2 (2 – 3)
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 The frequency of providing services to patients with 
diabetes is shown in  Table 3 . The overall medians (IQR) 
for each group of services were as follows: blood glucose 
monitoring: 2 (1–3), hypoglycemia management: 3 (2–3), 
general pharmacotherapy management including insulin 
and oral antidiabetic drugs: 3 (2–3), comorbid disease 
management: 2 (1–3), and healthy living choices: 2 (2–3).
 In general, pharmacists provided limited diabetes ser-
vices to patients, with no significant differences between 
those working in primary and secondary care ( p > 0.05). 
Respondents aged 30–39 years ( n = 71; 42.3%) and  ≥ 40 
years ( n = 36; 24.1%) provided the following services to 
patients more frequently than the younger age group
( n = 61; 36.3%): blood glucose monitoring ( p = 0.001 and 
0.004, respectively), hypoglycemia management ( p = 0.02 
and 0.04, respectively), general pharmacotherapy man-
agement including insulin and oral antidiabetic drugs
( p = 0.003 and 0.005, respectively), comorbid disease 
management ( p = 0.04 and <0.001, respectively), and 
healthy living choices ( p = 0.04 and 0.009, respectively). 
Male pharmacists ( n = 74; 44%) more frequently provid-
ed activities related to blood glucose monitoring ( p = 
0.03) and hypoglycemia management ( p = 0.02) than fe-
male pharmacists. Pharmacists practicing for more than 
10 years ( n = 77; 45.9%) more frequently provided ser-
vices such as blood glucose monitoring ( p = 0.03), hypo-
glycemia management ( p = 0.01), general pharmacother-
apy management including insulin and oral antidiabetic 
drugs ( p = 0.004), and comorbid disease management
( p = 0.01) compared to those with less experience. More-
over, graduates not from Kuwait University ( n = 113; 
67.3) provided diabetes services to patients more fre-
quently ( p <  0.001) than graduates of Kuwait University. 
There were no significant differences between the type of 
diabetes services provided to patients and respondents’ 
educational level, interest in diabetes, and completion of 
special diabetes continuing education ( p > 0.05). 
 The correlations between DAS-3 subscales and all 
groups of diabetic services are shown in  Table 4 . The re-
spondents with overall more positive diabetes-related at-
titudes were less frequently involved in providing glucose 
monitoring, comorbid disease management, and healthy 
living choices.
 Respondents identified “the image that some physi-
cians or patients have of pharmacists as dispensers only” 
as the most important barrier to providing diabetes care 
to patients and “lack of facilities (e.g., counseling room)” 
as the least important barrier. Other potential barriers in 
decreasing order included lack of collaboration with oth-
er health care providers, lack of organization, administra-
tive factors, and inadequate documentation. 
 Discussion  
 The key findings of this study showed that pharmacists 
had a general positive attitude toward diabetes manage-
ment. The most positive attitude was “the need for special 
training in patient education.” Despite their positive atti-
tude, they rarely provided advanced diabetes services to 
their patients, such as comorbid disease management. 
They regularly provided basic services such as patient 
counseling. The most important barrier to providing dia-
betes-related services was the perception that some physi-
cians and patients have of pharmacists as dispensers only. 
 The present study revealed that pharmacists had a gen-
eral positive attitude toward diabetes management, which 
is consistent with findings from previous studies  [14–16] 
that used DAS-3 as a tool to measure pharmacists’ dia-
betes-related attitudes. However, younger pharmacists 











DAS-3 –0.251** –0.173* –0.104 –0.243** –0.237**
Need for special training –0.139 –0.224** –0.039 –0.198* –0.100
Seriousness of type 2 diabetes –0.173* –0.081 –0.081 –0.212** –0.231**
Value of tight control –0.386** –0.316** –0.219** –0.277** –0.283**
Psychosocial impact of DM –0.073 –0.107 –0.051 –0.091 –0.049
Patient autonomy 0.003 0.122 –0.017 0.028 –0.005
DAS-3, Diabetes Attitude Scale-Version 3; DM, diabetes mellitus.  * Correlation is significant at the 0.05 level (2-tailed). ** Correla-
tion is significant at the 0.01 level (2-tailed).
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showed significantly more positive attitudes towards the 
need for special training compared to older pharmacists 
because of their inexperience. This is consistent with a 
previous study  [20] in which it was reported that younger 
and less experienced pharmacists were less prepared to 
perform patient education and other pharmaceutical care 
duties. Evidence has shown that people express their at-
titudes according to the knowledge gained throughout 
their lives  [21] . Additionally, it was found that pharma-
cists who graduated from Kuwait University showed sig-
nificantly more positive attitudes towards the following 
subscales: the need for special training, the severity of 
type 2 diabetes, and the value of tight control compared 
to non-Kuwait University pharmacists. This is consistent 
with a previous study, which indicated that pharmacy 
students in Kuwait University had positive attitudes and 
perceived that they were well prepared to provide phar-
maceutical care to patients in Kuwait  [22] . 
 Despite their general positive attitude towards diabe-
tes management, pharmacists in this study reported that 
they regularly provided patients with counseling about 
the appropriate time to administer medication; but not 
diabetes services related to hypoglycemia and comorbid 
disease management. This is consistent with previous re-
ports that only basic diabetes services, such as patient 
counseling was given on a regular basis  [15, 16] , but not 
the more complex tasks such as reviewing patients’ drug 
profiles to identify causes for poor blood pressure control. 
Equally important, pharmacists in both primary and sec-
ondary health care systems provided similar activities to 
patients with diabetes despite different caseloads. This 
might be due to the lack of local guidelines clarifying the 
accepted duties for pharmacists in wards or dispensaries, 
which may prevent pharmacists from participating in 
wider clinical roles in hospitals in Kuwait. Such guide-
lines and job descriptions are necessary for the improve-
ment of pharmacy practice in Kuwait  [17] . Hence, it is 
necessary to have a collaborative multilevel actions that 
could involve a broad stakeholder group to improve 
pharmaceutical care services provided to patients in Ku-
wait. Stakeholders could include the Ministry of Health 
as a policymaker, directors of hospitals and primary care 
centers as the managers of health care services, pharma-
cists as health care providers, and the Faculty of Phar-
macy as the only public school in Kuwait. 
 In this study, there was a negative correlation between 
overall DAS-3 scores/three DAS-3 subscales, and some of 
the diabetes-related services, which is consistent with a 
previous study  [15] that identified a negative correlation 
between the attitudes toward the difficulty of treating dia-
betes and pharmacists’ involvement in patient education. 
This negative correlation could indicate that pharmacists 
were not active in providing diabetes-related services to 
patients despite their beliefs that diabetes needs extensive 
patient education. This might be due to the less confi-
dence of the study participants in applying the knowledge 
and skills that they gained from their pharmacy education. 
Hence, they suggested the need for special diabetes train-
ing directed toward behavioral and communication skills. 
 The present study revealed that the highest ranked 
barrier to providing diabetes related services to patients 
was the perception that some physicians or patients have 
of pharmacists as dispensers only. This is consistent with 
other studies  [17, 23, 24] in which it was reported that ac-
ceptance from physicians and patients were among the 
top 5 greatest barriers to providing pharmaceutical care. 
This might be due to a lack of awareness of the pharma-
cists’ role in direct patient care among health care provid-
ers and the public. Hence, the need for closer cooperation 
between pharmacists and physicians is needed in Kuwait 
to build trust and confidence between health care profes-
sionals  [25] . Increased population awareness about the 
pharmacists’ role in the community would also aid in en-
suring a wider public acceptance of pharmacists’ contri-
butions to patient care  [26] . 
 The limitations of this study included the convenience 
sampling strategy based on only 1 health region out of the 
6 health care regions in Kuwait. The cross-sectional de-
sign represented 1 point in time and, therefore, could not 
reflect any dynamic changes in respondents’ attitudes 
and practice. In addition, respondents might have offered 
favorable answers to conform to the more socially accept-
ed view. Responses were taken at face value with no way 
of verifying respondents’ claims.
 Conclusions  
 This study demonstrated that pharmacists had posi-
tive diabetes-related attitudes; however, they provided 
limited diabetes-related services to patients. Barriers to 
providing increased pharmaceutical care services to pa-
tients with diabetes should be addressed to enable deliv-
ery of optimum care for people with diabetes in Kuwait. 
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